ReviewThe Canadian journal of cardiology2025
The Economics of Cardiac Rehabilitation in North, Central, and South America: A Narrative Review.
Review in The Canadian journal of cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cardiac Rehabilitation-Current Paradigms and Challenges Across the Cardiovascular Continuum.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Cardiac rehabilitation (CR) is an effective strategy for the secondary prevention of cardiovascular disease in individuals living with ischemic heart disease or heart failure, and among patients who have recently undergone cardiovascular surgery. Although CR is recommended by clinical guidelines and typically covered by payers, its uptake has been low. This is in part because of substantial economic barriers to accessing CR. Understanding the economics of CR from the perspective of various stakeholders -including patients, clinicians, health systems, and payers - is critical to developing strategies that optimize CR supply and demand, and increase uptake among populations most likely to benefit from this therapy. In this review, we summarize the currently available evidence, highlight current knowledge gaps, and identify key questions that should be prioritized in future research to guide the implementation of CR delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.